Tumor perfusion increases during hypofractionated short-course radiotherapy in rectal cancer: Sequential perfusion-CT findings

Radiotherapy and Oncology

Volumn 94, Issue 2, 2010, Pages 156-160

  Janssen, Marco H M ^a   Aerts, Hugo J W L ^a   Kierkels, Roel G J ^a,b   Backes, Walter H ^a   Öllers, Michel C ^a   Buijsen, Jeroen ^a   Lambin, Philippe ^a   Lammering, Guido ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Perfusion CT; Pharmacokinetic modeling; Rectal cancer; Short course hypofractionated radiotherapy; Tumor perfusion

Indexed keywords

CYTOTOXIC AGENT; FLUORODEOXYGLUCOSE; IODINATED CONTRAST MEDIUM;

ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; HISTOGRAM; HUMAN; ILIAC ARTERY; MUSCLE TISSUE; PERFUSION; PRIORITY JOURNAL; RECTUM CANCER; TREATMENT RESPONSE; TUMOR PERFUSION;

CONTRAST MEDIA; DOSE FRACTIONATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGING, THREE-DIMENSIONAL; IOHEXOL; MALE; NEOPLASM STAGING; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RECTAL NEOPLASMS; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77249157295     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.12.013     Document Type: Article

References (27)

1. Frykholm G., Glimelius B., and Pahlman L. Preoperative irradiation with and without chemotherapy (MFL) in the treatment of primarily non-resectable adenocarcinoma of the rectum. Results from two consecutive studies. Eur J Cancer Clin Oncol 25 (1989) 1535-1541
2. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351 (2004) 1731-1740
3. Sebag-Montefiore D. Developments in the use of chemoradiotherapy in rectal cancer. Colorectal Dis 8 (2006) 14-17
4. Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish rectal cancer trial. N Engl J Med 1997; 336: 980-987.
5. Kapiteijn E., Marijnen C.A., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345 (2001) 638-646
6. Peeters K.C., Marijnen C.A., Nagtegaal I.D., et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246 (2007) 693-701
7. Miles K.A. Perfusion CT for the assessment of tumour vascularity: which protocol?. Br J Radiol 76 (2003) S36-S42
8. Goh V., Padhani A.R., and Rasheed S. Functional imaging of colorectal cancer angiogenesis. Lancet Oncol 8 (2007) 245-255
9. Sahani D.V., Kalva S.P., Hamberg L.M., et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: initial observations. Radiology 234 (2005) 785-792
10. Bellomi M., Petralia G., Sonzogni A., Zampino M.G., and Rocca A. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: initial experience. Radiology 244 (2007) 486-493
11. Park M.S., Klotz E., Kim M.J., et al. Perfusion CT: noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy. Radiology 250 (2009) 110-117
12. Wang J., Wu N., Cham M.D., and Song Y. Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy. AJR Am J Roentgenol 193 (2009) 1090-1096
13. Harvey C., Dooher A., Morgan J., Blomley M., and Dawson P. Imaging of tumour therapy responses by dynamic CT. Eur J Radiol 30 (1999) 221-226
14. Tofts P.S., Brix G., Buckley D.L., et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 10 (1999) 223-232
15. Aerts H.J., van Riel N.A., and Backes W.H. System identification theory in pharmacokinetic modeling of dynamic contrast-enhanced MRI: influence of contrast injection. Magn Reson Med 59 (2008) 1111-1119
16. Zima A., Carlos R., Gandhi D., Case I., Teknos T., and Mukherji S.K. Can pretreatment CT perfusion predict response of advanced squamous cell carcinoma of the upper aerodigestive tract treated with induction chemotherapy?. AJNR Am J Neuroradiol 28 (2007) 328-334
17. Hermans R., Lambin P., Van der Goten A., et al. Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma. Radiother Oncol 53 (1999) 105-111
18. Hermans R., and Van den Bogaert W. Outcome prediction after surgery and chemoradiation of head-and-neck squamous cell carcinoma (HNSCC), using baseline perfusion computed tomography (CT) microcirculatory parameters vs. tumor volume. Int J Radiat Oncol Biol Phys 74 (2009) 1307 [author reply 1307]
19. Daisne J.F., Sibomana M., Bol A., Doumont T., Lonneux M., and Gregoire V. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol 69 (2003) 247-250
20. Ollers M., Bosmans G., van Baardwijk A., et al. The integration of PET-CT scans from different hospitals into radiotherapy treatment planning. Radiother Oncol 87 (2008) 142-146
21. Harrer J.U., Parker G.J., Haroon H.A., et al. Comparative study of methods for determining vascular permeability and blood volume in human gliomas. J Magn Reson Imaging 20 (2004) 748-757
22. Jackson A., Jayson G.C., Li K.L., et al. Reproducibility of quantitative dynamic contrast-enhanced MRI in newly presenting glioma. Br J Radiol 76 (2003) 153-162
23. Walker-Samuel S., Leach M.O., and Collins D.J. Reference tissue quantification of DCE-MRI data without a contrast agent calibration. Phys Med Biol 52 (2007) 589-601
24. Goh V., Halligan S., Hugill J.A., Gartner L., and Bartram C.I. Quantitative colorectal cancer perfusion measurement using dynamic contrast-enhanced multidetector-row computed tomography: effect of acquisition time and implications for protocols. J Comput Assist Tomogr 29 (2005) 59-63
25. Henderson E., Rutt B.K., and Lee T.Y. Temporal sampling requirements for the tracer kinetics modeling of breast disease. Magn Reson Imaging 16 (1998) 1057-1073
26. Kierkels R.G., Backes W.H., Janssen M.H., et al. Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer. Int J Radiat Oncol Biol Phys (2009)
27. Goh V., Halligan S., Gartner L., Bassett P., and Bartram C.I. Quantitative colorectal cancer perfusion measurement by multidetector-row CT: does greater tumour coverage improve measurement reproducibility?. Br J Radiol 79 (2006) 578-583